GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...
Speaker Two: That's the letter t. It makes the t sound. Speaker One: t, t, tiger. Aahh! Speaker Two: t, t, tractor. Speaker One: That's the letter p. It makes the p ...
Abstract: In remote sensing target detection cases, great challenges are faced when migrating detection models from the visible domain to the infrared domain. Cross-domain migration suffers from ...
Abstract: In today’s digital era, where information flows seamlessly and is readily available and accessible. However, these information and communication systems are highly dependent on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results